Ray Blind

Brooke Emerling, PhD, and Raymond Blind, PhD (seated, in foreground) at a 2023 scientific symposium they organized. Standing next to Blind is Hua Ya, PhD, from the City of Hope Comprehensive Cancer Center. Behind him in the light blue shirt is Emilio Hirsch, PhD, from the University of Torino, Italy.
June 7, 2024

Discovery raises hopes for new cancer therapy

The study connected the Hippo signaling pathway to phosphoinositides, a particular type of lipid, or fat molecule, which regulates cell functions that are critical in cancer, obesity and diabetes.

By Bill Snyder
Ray Blind, PhD
April 15, 2024

Ray Blind named associate director for diversity, equity and inclusion at Vanderbilt-Ingram Cancer Center

Ray Blind, PhD, Ingram Assistant Professor of Cancer Research, has been named associate director for Diversity, Equity and Inclusion at Vanderbilt-Ingram Cancer Center

By Tom Wilemon
Raymond Blind, PhD, left, Xin Tong, PhD, Rachana Haliyur, PhD, and Marcela Brissova, PhD, are part of a research team that discovered new information about the cellular dysfunction that occurs with a rare form of diabetes.
January 17, 2019

Study points to alternate therapy for rare form of diabetes

Vanderbilt University Medical Center researchers say an unexpected finding during the cellular analysis of human pancreatic tissue has revealed new information about a rare type of diabetes and underscores the importance of genetic testing for some individuals diagnosed with type 1 diabetes.

By Jill Clendening
November 17, 2016

V Foundation grants bolster cancer initiatives

Two Vanderbilt-Ingram Cancer Center (VICC) investigators have earned grant awards from The V Foundation for Cancer Research, continuing the foundation’s support for innovative cancer research initiatives at VICC.

By VUMC News and Communications